Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Mar 2020 for Enliven Therapeutics, Inc.. Read the official filing
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Lundbeck A. S. H: trading record in brief
Lundbeck A. S. H is a declared insider at 2 companies; the most frequent names are Alder Biopharmaceuticals Inc and Enliven Therapeutics, Inc. We count 2 filings; the first trade dates from 22 October 2019 and the latest from 16 March 2020.
The open-market record is one-sided, with 1 purchase and not one sale. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The record was last updated on 16 March 2020 with a transaction in Enliven Therapeutics, Inc. The latest purchase dates back some time: it was published 2,554 days ago, on 24 October 2019. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Lundbeck A. S. H
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
79,229 sharesCommon StockSEC:0000899243-20-008472:0
85,923,561 sharesCommon Stock, par value $0.0001SEC:0000899243-19-025918:0
Canonical exit: 20 Jan 2020 (T+90)
2 of 2 declarations
